Selected article for: "literature summarize and safety efficacy"

Author: Sethi, Atin; Bach, Horacio
Title: Evaluation of Current Therapies for COVID-19 Treatment
  • Cord-id: gy3ovkrt
  • Document date: 2020_7_22
  • ID: gy3ovkrt
    Snippet: The virus SARS-CoV-2, the etiological agent of COVID-19, is responsible for more than 400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance (December 2019), an efficacious treatment is not yet available. Although considered a lung infection since its emergence, COVID-19 is now causing multiple organ failure, requiring a continuous adjustment in the procedures. In this review, we summarize the current literature surrounding unproven therapies for COVID-19. Analyses of
    Document: The virus SARS-CoV-2, the etiological agent of COVID-19, is responsible for more than 400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance (December 2019), an efficacious treatment is not yet available. Although considered a lung infection since its emergence, COVID-19 is now causing multiple organ failure, requiring a continuous adjustment in the procedures. In this review, we summarize the current literature surrounding unproven therapies for COVID-19. Analyses of the clinical trials were grouped as chemotherapy, serotherapy, anticoagulant, and the use of human recombinant soluble ACE2 therapies. We conclude that, while no agent has hit the threshold for quality of evidence to demonstrate efficacy and safety, preliminary data show potential benefits. Moreover, there is a possibility for harm with these unproven therapies, and the decision to treat should be based on a comprehensive risk–benefit analysis.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and adrenal axis dysfunction: 1
    • abdominal pain and lmwh weight heparin: 1
    • abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
    • abdominal pain and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular lmwh weight heparin: 1
    • abdominal pain and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain vomiting and acute renal failure: 1, 2, 3
    • abdominal pain vomiting and adrenal axis dysfunction: 1
    • abdominal pain vomiting and lmwh weight heparin: 1
    • abdominal pain vomiting and lopinavir ritonavir: 1, 2, 3
    • abdominal pain vomiting and low molecular: 1
    • abdominal pain vomiting and low molecular lmwh weight heparin: 1
    • abdominal pain vomiting and lymphocyte count: 1, 2, 3
    • abdominal pain vomiting nausea and acute renal failure: 1, 2
    • abdominal pain vomiting nausea and adrenal axis dysfunction: 1
    • abdominal pain vomiting nausea and lopinavir ritonavir: 1
    • abdominal pain vomiting nausea and lymphocyte count: 1, 2
    • abdominal pain vomiting nausea diarrhea and lymphocyte count: 1
    • abdominal pain vomiting nausea diarrhea include and lymphocyte count: 1